Stock DMKPQ DMK PHARMACEUTICALS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News DMK Pharmaceuticals Corporation

Equities

DMKPQ

US00547W3079

Market Closed - OTC Markets
Other stock markets
 03:41:30 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.0503 USD +0.60% Intraday chart for DMK Pharmaceuticals Corporation -0.40% -92.82%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Apr. 04 North American Morning Briefing : Focus Turns to -2- DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge
DJ
North American Morning Briefing : Focus Turns to -2-
DJ
Bidding Procedure Approved for DMK Pharmaceuticals Corporation
CI
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation
CI
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index
CI
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation
CI
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index
CI
DMK Pharmaceuticals Commences Restructuring Proceeding
NE
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation
CI
DMK Pharmaceuticals Corporation Filed for Bankruptcy
CI
DMK Pharmaceuticals Corporation Announces Board Appointments
CI
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
AQ
Maxim Starts DMK Pharmaceuticals With Buy Rating, $1.50 Price Target
MT
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update
AQ
DMK Pharmaceuticals Corporation Regains Full Rights from US WorldMeds for SYMJEPI
CI
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) added to NASDAQ Composite Index
CI
Adamis Pharmaceuticals Corporation(NasdaqCM:ADMP) dropped from NASDAQ Composite Index
CI
DMK Pharmaceuticals: Q3 Earnings Snapshot
AQ
Earnings Flash (DMK) DMK PHARMACEUTICALS CORPORATION Reports Q3 Revenue $9,062
MT
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DMKPQ Stock
  4. News DMK Pharmaceuticals Corporation